Fore Biotherapeutics logo

Fore Biotherapeutics Funding & Investors

Philadelphia, PA

Fore Biotherapeutics is a precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics.

fore.bio

Total Amount Raised: $206,700,000

Fore Biotherapeutics Funding Rounds

  • Series D

    $40,200,000

    Series D Investors

    SR One
    Cormorant Asset Management
    HBM Healthcare Investments
    Wellington Management
    Novartis Venture Fund
    OrbiMed Advisors
    Medicxi
    3B Future Health Fund

  • Series D

    $75,000,000

    Series D Investors

    Medicxi
    SR One
    Cormorant Asset Management
    Samsung Securities
    3B Future Health Fund
    OrbiMed Advisors
    Wellington Management
    Novartis Venture Fund
    HBM Partners

  • Series C

    $57,000,000

    Series C Investors

    Pontifax
    Cormorant Asset Management
    HBM Healthcare Investments
    SR One
    Wellington Management
    OrbiMed Advisors
    Novartis Venture Fund

  • Series Unknown

    $6,000,000

    Series Unknown Investors

    SICAR
    Bio Capital Impact Fund
    Windham Venture Partners
    3B Future Health Fund

  • Series Unknown

    $2,500,000

    Series Unknown Investors

    OrbiMed Advisors

  • Series Unknown

    $10,000,000

    Series Unknown Investors

    Intercure

  • Seed

    $8,000,000

  • Seed

    $8,000,000

Funding info provided by Diffbot.